Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]

Annibale A. Puca; Gaia Spinetti; Rosa Vono; Carmine Vecchione; Paolo Madeddu

doi:10.1016/j.phrs.2017.01.029

Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]

Annibale A. Puca, Gaia Spinetti, Rosa Vono, Carmine Vecchione, Paolo Madeddu

Bristol Medical School (THS)

Research output: Contribution to journal › Comment/debate (Academic Journal)

332 Downloads (Pure)

Abstract

[No abstract]

Original language	English
Pages (from-to)	477
Number of pages	1
Journal	Pharmacological Research
Early online date	11 Feb 2017
DOIs	https://doi.org/10.1016/j.phrs.2017.01.029
Publication status	Published - May 2017

Access to Document

10.1016/j.phrs.2017.01.029

Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at https://www.sciencedirect.com/science/article/pii/S1043661817301123?via%3Dihub. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 97.8 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Fingerprint

Dive into the research topics of 'Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]'. Together they form a unique fingerprint.

Longevity-associated BPIFB4 gene therapy for treatment of ischemic disease
Madeddu, P. R. (Principal Investigator)
1/08/15 → 31/07/18
Project: Research

Cite this

Puca, A. A., Spinetti, G., Vono, R., Vecchione, C., & Madeddu, P. (2017). Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]. Pharmacological Research, 477. https://doi.org/10.1016/j.phrs.2017.01.029

@article{2528004ae03040238324ee75b28898ac,

title = "Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]",

abstract = "[No abstract]",

author = "Puca, {Annibale A.} and Gaia Spinetti and Rosa Vono and Carmine Vecchione and Paolo Madeddu",

year = "2017",

month = may,

doi = "10.1016/j.phrs.2017.01.029",

language = "English",

pages = "477",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Elsevier B.V.",

}

Puca, AA, Spinetti, G, Vono, R, Vecchione, C & Madeddu, P 2017, 'Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]', Pharmacological Research, pp. 477. https://doi.org/10.1016/j.phrs.2017.01.029

Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]. / Puca, Annibale A.; Spinetti, Gaia; Vono, Rosa et al.
In: Pharmacological Research, 05.2017, p. 477.

Research output: Contribution to journal › Comment/debate (Academic Journal)

TY - JOUR

T1 - Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]

AU - Puca, Annibale A.

AU - Spinetti, Gaia

AU - Vono, Rosa

AU - Vecchione, Carmine

AU - Madeddu, Paolo

PY - 2017/5

Y1 - 2017/5

N2 - [No abstract]

AB - [No abstract]

U2 - 10.1016/j.phrs.2017.01.029

DO - 10.1016/j.phrs.2017.01.029

M3 - Comment/debate (Academic Journal)

C2 - 28196703

SN - 1043-6618

SP - 477

JO - Pharmacological Research

JF - Pharmacological Research

ER -

Puca AA, Spinetti G, Vono R, Vecchione C, Madeddu P. Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]. Pharmacological Research. 2017 May;477. Epub 2017 Feb 11. doi: 10.1016/j.phrs.2017.01.029

Corrigendum to: “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair” [Pharmacol. Res. 114 (December) (2016) 169–174. doi: 10.1016/j.phrs.2016.10.028. Epub 2016 Nov 3]

Abstract

Access to Document

Handle.net

Fingerprint

Projects

Longevity-associated BPIFB4 gene therapy for treatment of ischemic disease

Cite this